Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

Rhea-AI Summary

Inotiv (Nasdaq: NOTV), a leading contract research organization, announced its participation in the 8th Annual Lake Street Best Ideas Growth Conference on September 12, 2024, in New York City. Robert Leasure Jr., President and CEO, and Beth Taylor, CFO, will represent the company at the event.

The conference provides an opportunity for Inotiv's management to host one-on-one meetings with investors and attendees. This engagement allows the company to showcase its expertise in nonclinical and analytical drug discovery and development services, as well as its offerings in research models and related products.

Investors interested in arranging meetings with Inotiv's leadership should contact their Lake Street conference representative to schedule appointments.

News Market Reaction – NOTV

+9.29%

+9.29% Session move

In the trading session that priced this news, NOTV gained 9.29%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WEST LAFAYETTE, Ind., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that Robert Leasure Jr., Inotiv’s President and Chief Executive Officer, and Beth Taylor, Chief Financial Officer, will participate in the 8^th Annual Lake Street Best Ideas Growth Conference on Thursday, September 12, 2024, in New York City.

Management is scheduled to host one-on-one meetings with investors and attendees during the conference. Investors interested in arranging one-on-one meetings should contact their Lake Street conference representative.

About Inotiv

Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here: https://www.inotiv.com/.

This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the impact of recent events related to non-human primate matters on the Company’s business, operations, results, financial condition, cash flows, and assets, the Company’s ability to service its outstanding indebtedness and comply with covenants under its credit agreement, compliance with the Resolution and Plea Agreements with the DOJ and the expected impacts on the Company related to the compliance plan, compliance monitor, and the expected financial commitments, changes in the market and demand for the Company’s products and services, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful closing, integration and business and financial impact thereof, governmental regulations, inspections and investigations, claims and litigation against or involving the Company, its business and/or its industry, the impact of site closures and consolidations, expansion and related efforts, and various other market and operating risks, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission.

Company Contact Inotiv, Inc. Beth A. Taylor, Chief Financial Officer (765) 497-8381 beth.taylor@inotiv.com

Investor Relations LifeSci Advisors Bob Yedid (516) 428-8577 bob@lifescieadvisors.com

FAQ

When and where is Inotiv (NOTV) participating in the Lake Street Best Ideas Growth Conference?

Inotiv (NOTV) is participating in the 8th Annual Lake Street Best Ideas Growth Conference on Thursday, September 12, 2024, in New York City.

Who will represent Inotiv (NOTV) at the Lake Street conference?

Robert Leasure Jr., President and CEO, and Beth Taylor, CFO, will represent Inotiv (NOTV) at the Lake Street conference.

What type of meetings will Inotiv (NOTV) management host during the conference?

Inotiv (NOTV) management is scheduled to host one-on-one meetings with investors and attendees during the conference.

How can investors arrange meetings with Inotiv (NOTV) management at the conference?

Investors interested in arranging one-on-one meetings with Inotiv (NOTV) management should contact their Lake Street conference representative.

What services does Inotiv (NOTV) specialize in as a contract research organization?

Inotiv (NOTV) specializes in nonclinical and analytical drug discovery and development services, as well as research models and related products and services.